NCT04387253View on ClinicalTrials.gov

Study of Late Fetal Loss in Poitou-Charentes. GYNE-COVID

NACompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

May 23, 2020

Primary Completion Date

June 17, 2022

Study Completion Date

June 17, 2022

Conditions
Identification of the Mother or Fetus Contamination by SARS Cov-2Research the Presence of Viruses at Different Sites of the Mother and the Fetus or FatherThe Survey Builds on a Network Work Already Organized Around the CPDPN of Poitou-CharentesAnalysis Laboratories of the Poitiers CHU
Interventions
DIAGNOSTIC_TEST

Identification by PCR of the SARS-COV-2 virus in samples taken from the fetus

Identification by PCR of the SARS-COV-2 virus in samples taken from the fetus Presence of SARS-COV-2 virus in samples taken from mother and father. Circulating anti-SARS-COV-2 antibodies in the mother.

Trial Locations (1)

86000

CHU de Poitiers, Poitiers

All Listed Sponsors
lead

Poitiers University Hospital

OTHER

NCT04387253 - Study of Late Fetal Loss in Poitou-Charentes. GYNE-COVID | Biotech Hunter | Biotech Hunter